Go Deep
Aarti Drugs Limited
Aarti Drugs Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,012 | 18.9 | 2.34 | 0.37 | 396.35 |
Aarti Drugs Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,027,800,000.0 | 7,203,000,000.0 | 6,017,100,000.0 | 6,527,900,000.0 |
| Net Profit | 501,700,000.0 | 551,900,000.0 | 405,400,000.0 | 452,800,000.0 |
| EPS | 5.5 | 6.0 | 4.4 | 5.0 |
Aarti Drugs Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 25,212,770,000.0 | 23,689,276,000.0 | 25,088,708,000.0 | 27,055,678,000.0 | — |
| Net Profit | 1,949,174,000.0 | 1,681,585,000.0 | 1,714,182,000.0 | 1,663,088,000.0 | — |
| EPS | 21.4 | 18.4 | 18.6 | 18.0 | — |
Aarti Drugs Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 28,152,642,000.0 | 25,746,782,000.0 | 24,323,580,000.0 | 24,213,982,000.0 | — |
| Total Liabilities | 12,660,386,000.0 | 12,053,354,000.0 | 11,504,037,000.0 | 12,287,302,000.0 | — |
| Total Equity | 15,488,610,000.0 | 13,689,985,000.0 | 12,815,485,000.0 | 11,924,347,000.0 | — |
Owes vs Owns
Aarti Drugs Limited owed ₹0.45 for every ₹1 it owned in Mar 2026, down from ₹0.51 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.45× | 0.47× | 0.47× | 0.51× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Aarti Drugs Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Receivables 29.5%Inventory 17.4%Fixed assets (tangible) 43.0%Intangible assets 3.9%Long-term investments 1.0%Other assets 5.0%
How it's funded — Mar 2026
Short-term debt 11.3%Long-term debt 9.1%Payables 17.5%Other liabilities 7.0%Shareholders' equity 55.0%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 8.2 | 7.0 | 8.9 | 8.4 |
| Receivables | 829.9 | 751.2 | 704.6 | 864.8 |
| Inventory | 490.8 | 472.9 | 485.9 | 516.3 |
| Fixed assets (tangible) | 1,210.7 | 1,149.9 | 1,053.9 | 885.9 |
| Intangible assets | 108.8 | 63.2 | 36.8 | 24.3 |
| Long-term investments | 27.3 | 22.4 | 20.0 | 18.8 |
| Other assets | 139.7 | 108.1 | 122.3 | 102.8 |
| Liabilities & equity | ||||
| Short-term debt | 318.0 | 328.2 | 287.1 | 401.8 |
| Long-term debt | 256.9 | 284.0 | 275.3 | 204.7 |
| Payables | 493.9 | 433.9 | 449.6 | 492.5 |
| Other liabilities | 197.4 | 159.2 | 138.4 | 129.7 |
| Shareholders' equity | 1,549.2 | 1,369.3 | 1,282.0 | 1,192.7 |
| Net tangible assets | 1,440.1 | 1,305.8 | 1,244.7 | 1,168.1 |
Aarti Drugs Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 2,535,385,000.0 | 2,445,838,000.0 | 3,589,232,000.0 | 1,333,212,000.0 | — |
| Investing Activities | -1,734,066,000.0 | -1,646,308,000.0 | -2,236,508,000.0 | -1,639,720,000.0 | — |
| Financing Activities | -774,435,000.0 | -821,185,000.0 | -1,360,331,000.0 | 165,422,000.0 | — |